Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.36 (
caspase-1
)
6,285
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inflammatory processes induced by IL-1beta are critical for host defence responses, but are also implicated in disease.
Zinc deficiency
is a common consequence of, or contributor to, human inflammatory disease. However, the molecular mechanisms through which zinc contributes to inflammatory disease remain largely unknown. We report here that zinc metabolism regulates
caspase-1
activation and IL-1beta secretion. One of the endogenous mediators of IL-1beta secretion is adenosine triphosphate, acting via the P2X7-receptor and
caspase-1
activation in cells primed with an inflammatory stimulus such as LPS. We show that this process is selectively abolished by a brief pre-treatment with the zinc chelator N,N,N',N'-tetrakis-(2-pyridylmethyl) ethylene diamine (TPEN). These effects on IL-1beta secretion were independent of rapid changes in free zinc within the cell, not a direct effect on
caspase-1
activity, and upstream of
caspase-1
activation. TPEN did however inhibit the activity of pannexin-1, a hemi-channel critical for adenosine triphosphate and nigericin-induced IL-1beta release. These data provide new insights into the mechanisms of
caspase-1
activation and how zinc metabolism contributes to inflammatory mechanisms.
...
PMID:Pannexin-1-dependent caspase-1 activation and secretion of IL-1beta is regulated by zinc. 1913 Apr 85